Arcadia Biosciences Business Summary

Arcadia Biosciences, Inc. (RKDA) operates as a consumer-centric wellness company, having pivoted from its legacy agricultural biotechnology roots to a pure-play healthy beverage model. The company generates the vast majority of its revenue through the sale of its Zola coconut water brand, which saw significant distribution expansion and double-digit year-over-year growth throughout 2025. Beyond product sales, Arcadia monetizes its intellectual property through the licensing and divestiture of agronomic wheat traits and maintains a strategic equity stake in Above Food Ingredients Inc. following the sale of its GoodWheat brand. In the competitive landscape, Arcadia positions itself as a micro-cap challenger to established players like The Vita Coco Company, CoAqua, and Coco5, while also competing for investor capital against small-cap agricultural and wellness firms such as CEA Industries and Nocera. Following the termination of a planned business combination with Roosevelt Resources in late 2025, the company is currently focused on optimizing its cost structure and evaluating strategic alternatives to maximize shareholder value. Leadership is spearheaded by Thomas J. Schaefer, who serves as President, Chief Executive Officer, and Interim Chief Financial Officer. Schaefer, a Chartered Financial Analyst (CFA) with an MBA from the USC Marshall School of Business, brings over 20 years of experience in corporate finance and equity research, having previously held senior roles at Flavor Producers and various Fortune 500 companies. The Board of Directors is led by Independent Chair Kevin Comcowich and includes experienced members such as Gregory Waller, Lilian Murray, and Amy Yoder. Recent governance shifts include the February 2026 resignations of directors Albert D. Bolles and Deborah Carosella, reflecting a streamlined board structure as the company navigates its turnaround phase. Notable historical backing has come from institutional investors such as Saints Capital and Mandala Capital, though current management is primarily focused on internal operational efficiency and the continued scaling of the Zola brand.